NCT04038619 2026-03-18
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
13 trialsNCT06424522 2026-01-20
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT05520723 2025-12-04
PRIMED
MedSIR
Phase 2 Completed
NCT06892093 2025-09-08
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT03094052 2025-06-26
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
University of California, San Francisco
Phase 2 Completed
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT05252988 2025-04-01
DIANER
Spanish Breast Cancer Research Group
Phase 2 Active not recruiting
NCT04823065 2024-05-13
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase 1/2 Completed
NCT04447443 2021-08-06
Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Withdrawn
NCT04736186 2021-02-03
Prevention and Treatment of Pyrrolitinib-associated Diarrhea
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT03705442 2018-10-15
Probat-tmcc-17
University Hospital Rijeka
Phase 2 Unknown
NCT02266849 2016-10-11
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
Odense University Hospital
Phase 3 Terminated
NCT02323516 2015-12-08
ASPIDIA
Centre Francois Baclesse
Phase 2 Withdrawn